Diclofenac

Product manufactured by Akorn, Inc.

Application Nr Approved Date Route Status External Links
ANDA077845 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage: Diclofenac Sodium Ophthalmic Solution, 0.1% Is Indicated For The Treatment Of Postoperative Inflammation In Patients Who Have Undergone Cataract Extraction And For The Temporary Relief Of Pain And Photophobia In Patients Undergoing Corneal Refractive Surgery.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Diclofenac Sodium DICLOFENAC SODIUM ZINC1281

Comments